LLY

992.37

-1.65%↓

JNJ

202.4

+0.3%↑

ABBV

225.23

-0.44%↓

UNH

325.35

-1.56%↓

AZN

90.25

+0.08%↑

LLY

992.37

-1.65%↓

JNJ

202.4

+0.3%↑

ABBV

225.23

-0.44%↓

UNH

325.35

-1.56%↓

AZN

90.25

+0.08%↑

LLY

992.37

-1.65%↓

JNJ

202.4

+0.3%↑

ABBV

225.23

-0.44%↓

UNH

325.35

-1.56%↓

AZN

90.25

+0.08%↑

LLY

992.37

-1.65%↓

JNJ

202.4

+0.3%↑

ABBV

225.23

-0.44%↓

UNH

325.35

-1.56%↓

AZN

90.25

+0.08%↑

LLY

992.37

-1.65%↓

JNJ

202.4

+0.3%↑

ABBV

225.23

-0.44%↓

UNH

325.35

-1.56%↓

AZN

90.25

+0.08%↑

Home・Akcijų sąrašas・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

34.09 -4.86

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

32.98

Max

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-1.8M -21M
Pardavimai	4.1M 83M
Pelnas, tenkantis vienai akcijai	-0.38
Pelno marža	-25.695
Darbuotojai	756
EBITDA	3.9M -20M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+47.32% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-221M 1.7B
Ankstesnė atidarymo kaina	38.95
Ankstesnė uždarymo kaina	34.09

Naujienos nuotaikos

By Acuity

50%

175 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

52.655 / 56.31 Palaikymas ir pasipriešinimas

PROCEPT BioRobotics Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-07 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

2025-12-05 21:08; UTC

Įsigijimai, susijungimai, perėmimai

Meta Platforms Buys AI-Device Maker Limitless

2025-12-05 19:39; UTC

Pagrindinės rinkos jėgos

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

2025-12-05 19:17; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

2025-12-07 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen -- Market Talk

2025-12-07 23:05; UTC

Rinkos pokalbiai

RBA Set to Remain 'Emphatically' On Hold, Westpac Says -- Market Talk

2025-12-07 22:18; UTC

Rinkos pokalbiai

RBA Set To Conclude Year With Hawkish Message -- Market Talk

2025-12-06 16:52; UTC

Įsigijimai, susijungimai, perėmimai

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

2025-12-06 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

2025-12-06 02:38; UTC

Įsigijimai, susijungimai, perėmimai

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

2025-12-05 21:59; UTC

Įsigijimai, susijungimai, perėmimai

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

2025-12-05 21:50; UTC

Rinkos pokalbiai

Uždarbis

Financial Services Roundup: Market Talk

2025-12-05 21:50; UTC

Įsigijimai, susijungimai, perėmimai

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

2025-12-05 21:36; UTC

Rinkos pokalbiai

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

2025-12-05 21:35; UTC

Įsigijimai, susijungimai, perėmimai

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

2025-12-05 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

2025-12-05 21:12; UTC

Rinkos pokalbiai

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

2025-12-05 21:03; UTC

Rinkos pokalbiai

Uždarbis

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

2025-12-05 21:01; UTC

Rinkos pokalbiai

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

2025-12-05 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

2025-12-05 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

2025-12-05 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

2025-12-05 20:01; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

2025-12-05 19:44; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-05 19:44; UTC

Rinkos pokalbiai

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

2025-12-05 19:39; UTC

Rinkos pokalbiai

Silver Climbs to a New Record High -- Market Talk

2025-12-05 19:31; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

2025-12-05 18:30; UTC

Rinkos pokalbiai

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

2025-12-05 18:28; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

2025-12-05 18:24; UTC

Įsigijimai, susijungimai, perėmimai

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

PROCEPT BioRobotics Corp Prognozė

Kainos tikslas

By TipRanks

47.32% į viršų

12 mėnesių prognozė

Vidutinis 52.83 USD 47.32%

Aukščiausias 65 USD

Žemiausias 50 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines PROCEPT BioRobotics Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

Pirkti

Laikyti

Parduoti

Remiantis 9 analitikų, pateikusių PROCEPT BioRobotics Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

52.655 / 56.31Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

175 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.